# ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/erbb3-mutations-in-cancer-biological-aspects-prevalence-and-therapeutics/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Nicolas Kiavué,Luc Cabel,Samia Melaabi,Guillaume Bataillon,Céline Callens,Florence Lerebours,Jean‐Yves Pierga,François‐Clément Bidard |
| Citations | 114 |
| DOI | 10.1038/s41388-019-1001-5 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2972418031 |
| PMID | 31519989 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Céline Callens](https://scholariq.org/researchers/celine-callens/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.